No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
HUMA240816C10000
- 1.18
- -0.07-5.60%
15min DelayTrading Jul 23 09:56 ET
1.30High0.90Low
1.11Open1.25Pre Close62 Volume4.32K Open Interest10.00Strike Price6.98KTurnover213.81%IV35.60%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry1.18Extrinsic Value100Contract SizeAmericanOptions Type0.4760Delta0.0868Gamma6.60Leverage Ratio-0.0378Theta0.0018Rho3.14Eff Leverage0.0085Vega
Intraday
- 5D
- Daily
News
Xeltis Appoints Shawn Gage as Vice President of US Clinical Affairs
What's Going On With Huamacyte Shares Tuesday?
Press Release: Humacyte Board of Directors Strengthened With Addition of John P. Bamforth and Keith Anthony Jones
Humacyte Board of Directors Strengthened With Addition of John P. Bamforth and Keith Anthony Jones
Humacyte Is Maintained at Buy by BTIG
Humacyte Price Target Raised to $11.00/Share From $8.00 by BTIG
Comments
2
$Humacyte(HUMA.US$ buy the ask for 14/15$ sake
$Humacyte(HUMA.US$
Support and Resistance Levels
Support @$8.99 , based on the recent bounce from this level, indicating a strong buyer's interest.
Resistance@ $9.97, where the price previously faced significant selling pressure, marking it as a challenging level to cross without substantial positive catalysts.
Support and Resistance Levels
Support @$8.99 , based on the recent bounce from this level, indicating a strong buyer's interest.
Resistance@ $9.97, where the price previously faced significant selling pressure, marking it as a challenging level to cross without substantial positive catalysts.
2
$Humacyte(HUMA.US$ key struggle levels to watch $9 , $11 & $15 to become consolidated supports or not …..
1
$Humacyte(HUMA.US$ today will green
Read more